L-carnitine therapy in isovaleric acidemia.
AUTOR(ES)
Roe, C R
RESUMO
Isovaleric acidemia, resulting from isovaleryl-coenzyme A dehydrogenase deficiency, is associated with marked reduction of free carnitine in both plasma and urine. Fast atom bombardment-mass spectrometry, hydrolysis, and gas chromatography/mass spectrometry have unequivocally identified the existence of isovalerylcarnitine, a new metabolite specific for this disorder. Administration of equimolar amounts of glycine or L-carnitine separately with leucine demonstrated that isovaleryl-coenzyme A is removed by supplemental L-carnitine in the form of isovalerylcarnitine as effectively as it is by glycine, in the form of isovalerylglycine. When L-carnitine is given alone, excretion of isovalerylglycine decreases in preference to enhanced excretion of isovalerylcarnitine and hippurate. Treatment with L-carnitine alone has proven effective in preventing further hospitalizations in a patient with this genetic disorder.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=425423Documentos Relacionados
- L-carnitine enhances excretion of propionyl coenzyme A as propionylcarnitine in propionic acidemia.
- Urinary excretion of L-carnitine, acetyl-L-carnitine, propionyl-L-carnitine and their antioxidant activities after single dose administration of L-carnitine in healthy subjects
- Effects of oral L-carnitine and DL-carnitine supplementation on alloxan-diabetic rats
- Role for Compatible Solutes Glycine Betaine and l-Carnitine in Listerial Barotolerance
- Effect of L-carnitine on exercise performance in patients with mitochondrial myopathy
